Leidos (NYSE: LDOS) director granted new stock and option awards

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Leidos Holdings director Harry M. Jansen Kraemer Jr. reported new equity awards in the company. He received 1,067 shares of Common Stock indirectly through the Key Executive Stock Deferral Plan, recorded as an acquisition rather than an open-market purchase.

He was also granted 1,281 stock options with a $131.26 exercise price, each convertible into one share of common stock. According to the award terms, the option vests in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholders’ meeting.

Following these transactions, Kraemer holds 93,281 shares of Common Stock directly and 130,472.1669 shares indirectly through the deferral plan, along with the newly granted 1,281 stock options.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider KRAEMER HARRY M JANSEN JR

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,281	$0.00	--
Grant/Award	Common Stock	1,067	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 1,281 shares (Direct, null); Common Stock — 130,472.167 shares (Indirect, By Key Executive Stock Deferral Plan); Common Stock — 93,281 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Common shares granted (indirect): 1,067 shares Stock options granted: 1,281 options at $131.26 Option expiration date: May 7, 2033 +3 more

6 metrics

Common shares granted (indirect) 1,067 shares Award via Key Executive Stock Deferral Plan on May 8, 2026

Stock options granted 1,281 options at $131.26 Option grant on May 8, 2026, exercise price per share

Option expiration date May 7, 2033 Expiration of 1,281 stock options granted May 8, 2026

Direct common shares after transaction 93,281 shares Direct holdings of Leidos common stock following reported awards

Indirect common shares after transaction 130,472.1669 shares Held via Key Executive Stock Deferral Plan after awards

Options outstanding after grant 1,281 options Stock Option (Right to Buy) position following transaction

Key Terms

Key Executive Stock Deferral Plan, Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, +1 more

5 terms

Key Executive Stock Deferral Plan financial

"nature_of_ownership: "By Key Executive Stock Deferral Plan""

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

exercise price financial

"conversion_or_exercise_price: "131.2600" per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest and become exercisable financial

"The option shall vest and become exercisable in full on the earlier of..."

Form 4 Insider Transactions: What Each Field Means →

05/12/2026 - 08:56 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KRAEMER HARRY M JANSEN JR

(Last)

(First)

(Middle)

1750 PRESIDENTS STREET

(Street)

RESTON

VIRGINIA

20190

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/08/2026		A		1,067	A	$0	130,472.1669	I	By Key Executive Stock Deferral Plan
Common Stock								93,281	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$131.26	05/08/2026		A		1,281		05/08/2027⁽¹⁾	05/07/2033	Common Stock	1,281	$0	1,281	D

Explanation of Responses:

1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Remarks:

	/s/ Ramune M. Kligys by PoA of Harry M. Jansen Kraemer, Jr.	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Leidos (LDOS) director Harry Kraemer acquire in this Form 4?

Leidos director Harry M. Jansen Kraemer Jr. received equity awards, not open-market purchases. He acquired 1,067 common shares via the Key Executive Stock Deferral Plan and 1,281 stock options, both recorded as compensation-related grants under transaction code A.

How many Leidos (LDOS) shares does Harry Kraemer hold after the reported transactions?

After the transactions, Harry Kraemer holds 93,281 Leidos common shares directly and 130,472.1669 shares indirectly through the Key Executive Stock Deferral Plan, plus 1,281 newly granted stock options, giving him a substantial combined equity position in the company.

What are the terms of Harry Kraemer’s new Leidos (LDOS) stock options?

Kraemer’s new Leidos stock options cover 1,281 shares at a $131.26 exercise price. The options vest in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholders’ meeting, and expire on May 7, 2033.

Is the Leidos (LDOS) Form 4 transaction a market buy or a compensation grant?

The Form 4 reflects compensation grants, not market buys. Both the 1,067 common shares and 1,281 stock options are coded A, described as a grant, award, or other acquisition, indicating they were issued as part of Leidos’ executive compensation arrangements.

How is indirect ownership reported for Leidos (LDOS) director Harry Kraemer?

Indirect ownership is reported through the Key Executive Stock Deferral Plan. Kraemer is shown holding 130,472.1669 Leidos common shares indirectly, with the nature of ownership specifically labeled as “By Key Executive Stock Deferral Plan” in the Form 4 disclosure.